Rchr
J-GLOBAL ID：201201061502266481
Update date: Apr. 06, 2024
Yamazaki Etsuko
ヤマザキ エツコ | Yamazaki Etsuko
Affiliation and department：
Job title：
Director
Homepage URL (1)：
http://www.yokohama-cu.ac.jp/fukuhp/section/central_section/laboindex.html
Research keywords (1)：
LaboratoryHematology
Papers (21)：
-
Haruka Teshigawara-Tanabe, Maki Hagihara, Jun Aoki, Satoshi Koyama, Hiroyuki Takahashi, Yuki Nakajima, Hiroyoshi Kunimoto, Takayoshi Tachibana, Takuya Miyazaki, Kenji Matsumoto, et al. Clinical risk factors for patients with myelodysplastic syndromes undergoing allogeneic hematopoietic stem cell transplantation. Hematology. 2022. 27. 1. 620-628
-
Takahiko Yasuda, Masashi Sanada, Masahito Kawazu, Shinya Kojima, Shinobu Tsuzuki, Hiroo Ueno, Eisuke Iwamoto, Yuka Iijima-Yamashita, Tomomi Yamada, Takashi Kanamori, et al. Two novel high-risk adult B-cell acute lymphoblastic leukemia subtypes with high expression of CDX2 and IDH1/2 mutations. Blood. 2022. 139. 12. 1850-1862
-
Takeshi Saito, Yoshihiro Hatta, Fumihiko Hayakawa, Tsutomu Takahashi, Maki Hagihara, Hiroatsu Iida, Koichiro Minauchi, Etsuko Yamazaki, Isamu Sugiura, Tohru Murayama, et al. Combination of clofarabine, etoposide, and cyclophosphamide in adult relapsed/refractory acute lymphoblastic leukemia: a phase 1/2 dose-escalation study by the Japan Adult Leukemia Study Group. International journal of hematology. 2021. 113. 3. 395-403
-
Hiroyoshi Kunimoto, Yumi Fukuchi, Koichi Murakami, Junji Ikeda, Hiroshi Teranaka, Ikuma Kato, Takuya Miyazaki, Makiko Enaka, Takayuki Mitsuhashi, Etsuko Yamazaki, et al. Establishment of a High-risk MDS/AML Cell Line YCU-AML1 and its Xenograft Model Harboring t(3;3) and Monosomy 7. HemaSphere. 2020. 4. 5. e469-e469
-
Taiki Ando, Shin Fujisawa, Haruka Teshigawara, Ayako Matsumura, Takayuki Sakuma, Taisei Suzuki, Hiroshi Teranaka, Eriko Ogusa, Yoshimi Ishii, Kazuho Miyashita, et al. Computed tomography-defined sarcopenia: prognostic predictor of nonrelapse mortality after allogeneic hematopoietic stem cell transplantation: a multicenter retrospective study. International journal of hematology. 2020. 112. 1. 46-56
ｍore...
MISC (75)：
-
Hiroyuki Takahashi, Hideaki Kato, Ayako Matsumura, Kazuho Miyashita, Sei Samukawa, Yuki Nakajima, Maki Hagihara, Etsuko Yamazaki, Shin Fujisawa, Hideaki Nakajima. Corynebacterium blood stream infection among hematological malignancy patients with neutropenia: a case series analysis. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2017. 50. S60-S60
-
Taiki Ando, Etsuko Yamazaki, Haruka Teshigawara, Eriko Ogusa, Yoshimi Ishii, Kazuho Miyashita, Kenji Motohashi, Takuya Miyazaki, Takayoshi Tachibana, Maki Hagihara, et al. Impact of the Difference in Body Mass Index at Transplantation from That at Diagnosis for Graft-Versus-Host Disease-Free, Relapse-Free Survival in Acute Myeloid Leukemia. BLOOD. 2016. 128. 22
-
高橋 寛行, 萩原 真紀, 勅使川原 晴佳, 松村 彩子, 三宅 暁夫, 中嶋 ゆき, 江中 牧子, 宮崎 拓也, 松本 憲二, 山崎 悦子, et al. クローンの相同性が示唆された、未分化大細胞T細胞リンパ腫合併低悪性度T細胞白血病の1例. 臨床血液. 2016. 57. 11. 2428-2428
-
Naoto Tomita, Taisei Suzuki, Kazuho Miyashita, Wataru Yamamoto, Kenji Motohashi, Takayoshi Tachibana, Hirotaka Takasaki, Rika Kawasaki, Maki Hagihara, Chizuko Hashimoto, et al. The Sil Index Is a Useful Prognostic Indicator for Diffuse Large B-Cell Lymphoma. BLOOD. 2015. 126. 23
-
Taiki Ando, Etsuko Yamazaki, Haruka Teshigawara, Fujii Eriko, Yoshimi Ishii, Wataru Yamamoto, Kenji Motohashi, Takayoshi Tachibana, Maki Hagihara, Kenji Matsumoto, et al. Body Mass Index Is a Prognostic Factor in Adults with Newly Diagnosed Acute Myeloid Leukemia: A Retrospective Multi-Institutional Study in Japan. BLOOD. 2015. 126. 23
ｍore...
Professional career (1)：
Return to Previous Page
